Martin and Harris Laboratories: Financial Results for FY24
Written by: Diksha Kalra
Published: Sep 16, 2026
Updated: Sep 16, 2026
1 min read
- Revenue- In FY24, the company's revenue dropped by 29%, declining from Rs. 205 cr in FY23 to Rs. 146 cr, primarily due to a decrease in goods sales. Additionally, the company's net income fell by 41%, going from Rs. 68 cr in FY23 to Rs. 40 cr in FY24, which led to a 41% reduction in EPS, down from Rs. 170 in FY23 to Rs. 101 in FY24.
- Financial Position- The company's total assets grew by 8%, rising from Rs. 615 cr in FY23 to Rs. 662 cr in FY24. Similarly, total equity increased by 7%, moving from Rs. 593 cr in FY23 to Rs. 632 cr in FY24.
Stay Connected, Stay Informed –
Join Our
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
